Federation Des Caisses Desjardins Du Quebec Rigel Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Aug 30, 2024
SELL
$3.35 - $4.93 $16,750 - $24,650
-5,000 Closed
0 $0
Q4 2020

Aug 30, 2024
BUY
$2.35 - $3.74 $11,750 - $18,700
5,000 New
5,000 $17.5 Million
Q1 2020

Aug 30, 2024
SELL
$1.27 - $3.0 $18,564 - $43,854
-14,618 Closed
0 $0
Q4 2019

Aug 30, 2024
BUY
$1.6 - $2.43 $23,388 - $35,521
14,618 New
14,618 $31.2 Million

Others Institutions Holding RIGL

# of Institutions
9
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $3B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email